Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine Moving into Clinical Evaluation for HCC Strong Cash Position Supports Continued Strategic Execution Conference Call Scheduled: August 21 at...
SAN JOSE, Calif., Aug. 7, 2026 /PRNewswire/ -- At FMS 2026 on August 5, Longsys (301308.SZ) Chief Scientist Dr. Jian Chen delivered a keynote speech...
The new B2B resource helps procurement, formulation, and quality teams evaluate PQQ production methods, ingredient identity, testing, stability, packaging, and supply continuity. Key...
SHANGHAI, Aug. 7, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the...
HONG KONG, Aug. 7, 2026 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) has achieved a landmark milestone at the...